{"id":969744,"date":"2026-06-02T16:19:08","date_gmt":"2026-06-02T20:19:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/"},"modified":"2026-06-02T16:19:08","modified_gmt":"2026-06-02T20:19:08","slug":"crescent-biopharma-to-present-at-june-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/","title":{"rendered":"Crescent Biopharma to Present at June Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WALTHAM, Mass., June  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lcq6omn9jXePHdZ-8-IB4JEsJZFej-yEjdA2mo5mO38ZenWg_3XXR1-Nbw9PUkOJbWD3FfRJE_7DwKrDotqhwQK4CbHtAPzd-l4fp5obt0-hWMvHHvdM7iXhkIXKAwSE\" rel=\"nofollow\" target=\"_blank\">Crescent Biopharma, Inc.<\/a> (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>2026 Jefferies Global Healthcare Conference, <\/strong>fireside chat on Wednesday, June 3, 2026 at 4:20 p.m. ET in New York<\/li>\n<li>\n          <strong>Goldman Sachs 47<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Healthcare Conference, <\/strong>fireside chat on Monday, June 8, 2026 at 8:40 a.m. ET in Miami<\/li>\n<\/ul>\n<p>A live webcast of each presentation will be available in the Investors section of Crescent&#8217;s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wetwh2u7Qur1-TB8_cYd7XrcCdIgQuBVip4egy90ltQ2grXx6P74p7IrjLEk2kYEmkrCeMR2WWAY8-j5179CepS-x1nWwEcDZQKSVRLDB5obKrOQnk0D8obI4c2L-3KmjhuxTo1zPVag-abKzRY-c8AOcleopPBVEc3eDeAe1u8luLK9QJk2PV2F7RqR0ln2-iisKbBCDujdAeNaOSyY7Q==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.crescentbiopharma.com\/events-presentations<\/a>, and a replay will be accessible for 90 days.<\/p>\n<p>\n        <strong>About Crescent Biopharma<\/strong>\n      <\/p>\n<p>Crescent Biopharma\u2019s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company\u2019s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lT885hd28T9yb58g8YXE5JWyOwdwy68B2ZM5d3yp9pF1Sa_hf3jzIa1Ax16WQN2lWVG3tbhWO4K6_awkKv5JRvRGayI1lHFTx18oskFKYBngUU9rXJjXTHGppyucgmb_\" rel=\"nofollow\" target=\"_blank\">www.crescentbiopharma.com<\/a>\u00a0and follow the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AjsQ-uk8NAXtYE_vAJRGwEZZUsTtrfCf6ArlFnOTkf5-jpqk2khqbxpDzUh-V-niCwR48pFlJR9Tsy8cXil2zWlAZkKmClB6j6SuOLM30d1cYce0xcQhhD8XtU39KBYS\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=22QkfRtW7NcrL3asTAVpx6KA4vlqbtbuAi-Ox0aDFVoMWAg9SYcSGAI4b8jA8cmGbM7l8xZbh4Tbtgs5zSmSRw==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Amy Reilly<br \/>Chief Communications Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5aGO-SRhrrjos76Dl-zw3OXBRh6CMkok5378DGZCk5zTgWbVgJ7gNt1RhI52QCmjXp38try5b0nMi5MToart59XqNr_xLZ9DzG2lVJCTcoLmaoLYQ2uXuFWrVtm0-Mj_qD---wtWqEOAGdIx4FaHMQ==\" rel=\"nofollow\" target=\"_blank\">amy.reilly@crescentbiopharma.com<\/a><br \/>617-465-0586<\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <br \/>Jenna Poist<br \/>Director, Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tOag2jbpVv9A2lrgAKR6z90QYZLm6_uSRSAQy_q31tUU98w62o-DtBe24GlnFk3w9lv8tSoiPToWRuaJAuEYmjiCMlj1eu1b12TDJNW_9kpuHGzOqPOuqoDHlsWmpkeOwRr-nsCdVg6yUnV29a4Bww==\" rel=\"nofollow\" target=\"_blank\">jenna.poist@crescentbiopharma.com<\/a><br \/>781-671-5019<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTQzZjJjMjMtMjk0Zi00YmY4LTk5MzUtYmM5NDhlMzhiOWFlLTEzMTAwMzAtMjAyNi0wNi0wMi1lbg==\/tiny\/Crescent-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June: 2026 Jefferies Global Healthcare Conference, fireside chat on Wednesday, June 3, 2026 at 4:20 p.m. ET in New York Goldman Sachs 47 th Annual Global Healthcare Conference, fireside chat on Monday, June 8, 2026 at 8:40 a.m. ET in Miami A live webcast of each presentation will be available in the Investors section of Crescent&#8217;s website at\u00a0https:\/\/investors.crescentbiopharma.com\/events-presentations, and a replay will be accessible for 90 days. About Crescent Biopharma Crescent Biopharma\u2019s vision &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Crescent Biopharma to Present at June Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-969744","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crescent Biopharma to Present at June Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crescent Biopharma to Present at June Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June: 2026 Jefferies Global Healthcare Conference, fireside chat on Wednesday, June 3, 2026 at 4:20 p.m. ET in New York Goldman Sachs 47 th Annual Global Healthcare Conference, fireside chat on Monday, June 8, 2026 at 8:40 a.m. ET in Miami A live webcast of each presentation will be available in the Investors section of Crescent&#8217;s website at\u00a0https:\/\/investors.crescentbiopharma.com\/events-presentations, and a replay will be accessible for 90 days. About Crescent Biopharma Crescent Biopharma\u2019s vision &hellip; Continue reading &quot;Crescent Biopharma to Present at June Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T20:19:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Crescent Biopharma to Present at June Investor Conferences\",\"datePublished\":\"2026-06-02T20:19:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/\"},\"wordCount\":233,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/\",\"name\":\"Crescent Biopharma to Present at June Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=\",\"datePublished\":\"2026-06-02T20:19:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crescent-biopharma-to-present-at-june-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crescent Biopharma to Present at June Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crescent Biopharma to Present at June Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Crescent Biopharma to Present at June Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) &#8212; Crescent Biopharma, Inc. (\u201cCrescent\u201d or the \u201cCompany\u201d) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June: 2026 Jefferies Global Healthcare Conference, fireside chat on Wednesday, June 3, 2026 at 4:20 p.m. ET in New York Goldman Sachs 47 th Annual Global Healthcare Conference, fireside chat on Monday, June 8, 2026 at 8:40 a.m. ET in Miami A live webcast of each presentation will be available in the Investors section of Crescent&#8217;s website at\u00a0https:\/\/investors.crescentbiopharma.com\/events-presentations, and a replay will be accessible for 90 days. About Crescent Biopharma Crescent Biopharma\u2019s vision &hellip; Continue reading \"Crescent Biopharma to Present at June Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-02T20:19:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Crescent Biopharma to Present at June Investor Conferences","datePublished":"2026-06-02T20:19:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/"},"wordCount":233,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/","name":"Crescent Biopharma to Present at June Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=","datePublished":"2026-06-02T20:19:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDY1NCM3NjMzMTY0IzIyOTg0ODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crescent-biopharma-to-present-at-june-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Crescent Biopharma to Present at June Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969744","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=969744"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969744\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=969744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=969744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=969744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}